[1] Verani MS. Thalliun-201 Single-Photon emission co-mputedtomography (SPECT) in the assessment of coronary artery disease[J]. Am JCardiol, 1992, 70(14):3E-9E. [2]Gould KL. Clinical cardiac positron emission tomo-graphy:state of the art [J]. Circulation, 1991,84: I.22-I.36. [3]Bergmann SR, Fox KA, Rand AL, et al. Quantificationof regional myocardial blood flow in vivo with H215O[J].Circulation, 1984, 70:724-733. [4]Tamaki N, Yonekura Y, et al. Value and limitationof stress thallium-201 single photon emission computed tomography: comparisonwith nitrogen-13 ammonia positron tomography[J]. J Nucl Med, 1988, 29:1181-1188. [5]Stewart RE, Schwaiger M, Molina E, et al.Comparison of rubidium-82 positron emission tomography and thallium-201 SPECTimaging for detection of coronary artery disease[J]. Am J Cardiol ,1991, 67:1303-1310. [6]牟甜甜, 张现忠. PET心肌灌注显像剂[J]. 化学进展, 2012, 24(10): 1966-1973.MouTiantian, Zhang Xianzhong. Myocardial perfusion imaging agents for positronemission tomography[J]. Progress in Chemistry, 2012, 24(10): 1966-1973(in Chinese). [7]Andrei RS, Marc S. Berridge. Synthesis andproperties of 18F-labeledpotential myocardial blood flow tracers[J]. J Nucl Med, 2001, 28(6):683-693. [8]Igal Madar, Hayden T.Ravert, Yong Du, et al.Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenylphosphonium in dog myocardium[J]. J Nucl Med, 2006, 47:1359-1366. [9]Dong-Yeon Kim, Hee-Jung Kim, et al. Synthesis of [18F]-labeled(2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl) phosphonium cation as a potential agent for positronemission tomography myocardial imaging[J]. J Nucl Med, 2012, 39:1093-1098. [10]Ming Yu, Mary T,Guaraldi MK,et al. BMS-747158-02:A novel PET myocardial perfusion imaging agent[J]. J Nucl Cardiol, 2007,14(6):789-798. [11]Tiantian Mou, Zuoquan Zhao, Wei Fang, et al.Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues formyocardial perfusion imaging with PET[J]. JNucl Med, 2012, 53(3): 472-479. [12]Nikolaj N. Ryzhikov, Nicholas Seneca, et al. Preparationof highly specific radioactivity 18F-flumazeniland its evaluation in cynomolgus monkey by positron emission tomography[J]. JNucl Med, 2005, 32:109-116. [13]Chyng-Yann Shiue, GraceG. Shiue, et al. P-[18F]-MPPF: A potential radioligand for PET studies of 5-HT1A receptors in humans[J].Synapse, 1997, 25(2):147-154. |